Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term efficacy of clindamycin + benzoyl peroxide gel vs clindamycin lotion in mild to moderate hidradenitis suppurativa
2018-004338-13Phase 4Active
- Sponsor
- Erasmus MC
- Start
- May 2019
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of clindamycin + benzoyl peroxide in hidradenitis suppurativa (HS) (2 arms), sponsored by Erasmus MC. Primary endpoint: Frequency of flares (active lesions) over 12 weeks. Started May 2019; status: active.
02
Drugs
clindamycin + benzoyl peroxide
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on 2018-004338-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004338-13.